Overall survival · hormone‐sensitive prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · hormone‐sensitive prostate cancer
Degarelix showed no clear difference in serious adverse events compared with standard androgen suppression therapy (low certainty).
1 finding from 1 review
Quality of life · hormone‐sensitive prostate cancer
1 finding from 1 review
Cancer‐specific survival (24 months) (Number of cancer‐related deaths) · hormone‐sensitive prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular events · hormone‐sensitive prostate cancer
It is very uncertain whether degarelix changes cardiovascular events compared with standard androgen suppression therapy (very low certainty).
1 finding from 1 review
Injection site pain · hormone‐sensitive prostate cancer
Degarelix probably leads to higher injection site pain compared with standard androgen suppression therapy (moderate certainty).
1 finding from 1 review
Erectile function · men with ED
2 findings from 1 review
Adverse events · men with ED
Ginseng showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported ability to have intercourse · men with ED
Ginseng may leads to higher participant's ability to have intercourse reported by participant… compared with placebo (low certainty).
1 finding from 1 review
Sexual satisfaction · men with ED
2 findings from 1 review
Quality of life ‐ not measured · men with ED
The review found no eligible studies for this question.
1 finding from 1 review
Participant perception of change with treatment · adult men with premature ejaculation
SSRI probably leads to higher participant perception of change with treatment compared with placebo (moderate certainty).
1 finding from 1 review
Participant satisfaction with intercourse · adult men with premature ejaculation
SSRI probably leads to higher participant satisfaction with intercourse compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adult men with premature ejaculation
SSRI may leads to higher study withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Perceived control over ejaculation · adult men with premature ejaculation
SSRI probably leads to higher perceived control over ejaculation compared with placebo (moderate certainty).
1 finding from 1 review
Participant distress about PE · adult men with premature ejaculation
SSRI probably leads to higher participant distress about PE compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · adult men with premature ejaculation
SSRI probably leads to higher adverse events compared with placebo (moderate certainty).
1 finding from 1 review
IELT · adult men with premature ejaculation
1 finding from 1 review
Intervention not reported
studies 1847 participants · men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments…
1 finding from 1 review
Intervention not reported
CRFWVT (Rezūm) (indirect estimate) · men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments…
1 finding from 1 review
no estimate extracted
Studies not reported
Low